Market Tracker

05/26 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

34.90
Delayed Data
As of May 26
 -0.37 / -1.05%
Today’s Change
16.64
Today|||52-Week Range
51.99
-2.10%
Year-to-Date

Today’s Trading

Previous close35.27
Today’s open35.05
Day’s range34.35 - 35.22
Volume1,772,510
Average volume (3 months)3,055,373
Market cap$4.0B
Dividend yield--
Data as of 4:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-71.58%
Earnings growth (this year)-9.20%
Earnings growth (next 5 years)+18.27%
Revenue growth (last year)-49.17%
P/E ratioNM
Price/Sales58,810.80
Price/Book18.00

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.73-1.57%
GRFSGrifols SA+0.18+1.14%
AKRXAkorn Inc-0.65-2.14%
ANACAnacor Pharmaceutica...+0.83+0.84%
Data as of 4:00pm ET, 05/26/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$61.0K
Annual profit (last year)-$164.4M
Net profit margin-269,578.69%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts